title: Experience with oseltamivir for infants younger than 1 year old in Japan.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Okamoto
authors.forename: Ichiro
authors.initials: I
authors.lastname: Kamiya
authors.forename: Kenji
authors.initials: K
authors.lastname: Kishida
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Shimakawa
authors.forename: Tsuguya
authors.initials: T
authors.lastname: Fukui
authors.forename: Takeshi
authors.initials: T
authors.lastname: Morimoto
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007251:Influenza, Human / Q000150:complications / Q000188:drug therapy* / Q000401:mortality*; D020258:Neurotoxicity Syndromes / Q000453:epidemiology* / Q000401:mortality; D053139:Oseltamivir
chemical_list: D000081:Acetamides; D000998:Antiviral Agents; D053139:Oseltamivir